Dembele, Laurent
Diakite, Ousmaila
Sogore, Fanta
Kedir, Soriya
Tandina, Fatalmoudou
Maiga, Mohamed
Abate, Andargie
Golassa, Lemu
Djimde, Abdoulaye A.
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-015996)
Article History
Received: 9 March 2023
Accepted: 7 June 2023
First Online: 13 June 2023
Declarations
:
: The authors declare no competing interests.
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Addis Ababa University, Aklilu Lemma Institute of Pathobiology (reference no. ALIPB IRB/18/2012/20), and the National Research Ethics Review Committee (reference no. MoSHE/02/152/778/21). Written informed consent was obtained from all participants. The study participants were informed that they could be treated according to the national treatment guideline if positive for malaria. The participants and/or their guardians were given the right to refuse to take part in the study, as well as to withdraw at any time during the study. No names or identifying information were indicated on the questionnaires, and all subjects were assured of confidentiality throughout the study.
: Not Applicable.